NCT07085767
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07085767
Title Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-02)
Acronym OPERA-02
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Olema Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | GBR | CAN | AUS

Facility Status City State Zip Country Details
Clinical Trial Site RECRUITING Denver Colorado 80220 United States Details
Clinical Trial Site ACTIVE_NOT_RECRUITING Ames Iowa 50010 United States Details
Clinical Trial Site RECRUITING Scarborough Maine 04074 United States Details
Clinical Trial Site RECRUITING Kansas City Missouri 64132 United States Details
Clinical Trial Site RECRUITING Santa Fe New Mexico 87505 United States Details
Clinical Trial Site RECRUITING Columbus Ohio 43219 United States Details
Clinical Trial Site RECRUITING Sayre Pennsylvania 18840 United States Details
Clinical Trial Site ACTIVE_NOT_RECRUITING Tennessee City Tennessee 37203 United States Details
Clinical Trial Site NOT_YET_RECRUITING Salt Lake City Utah 84106 United States Details
Clinical Trial Site ACTIVE_NOT_RECRUITING Olympia Washington 98502 United States Details
Clinical Trial Site RECRUITING Sydney New South Wales 2109 Australia Details
Clinical Trial Site RECRUITING Waratah New South Wales 2298 Australia Details
Clinical Trial Site ACTIVE_NOT_RECRUITING South Brisbane Queensland 4101 Australia Details
Clinical Trial Site RECRUITING Adelaide South Australia 5000 Australia Details
Clinical Trial Site RECRUITING Clayton Victoria 3168 Australia Details
Clinical Trial Site RECRUITING Geelong Victoria 3220 Australia Details
Clinical Trial Site ACTIVE_NOT_RECRUITING Heidelberg Victoria 3084 Australia Details
Clinical Trial Site RECRUITING Nedlands Western Australia 6009 Australia Details
Clinical Trial Site RECRUITING Toronto Ontario M2J 1V1 Canada Details
Clinical Trial Site ACTIVE_NOT_RECRUITING Hong Kong Hong Kong 999077 Hong Kong Details
Clinical Trial Site RECRUITING Hong Kong Kowloon 999077 Hong Kong Details
Clinical Trial Site ACTIVE_NOT_RECRUITING Hong Kong Pok Fu Lam 999077 Hong Kong Details
Clinical Trial Site ACTIVE_NOT_RECRUITING Kuching Sarawak 93586 Malaysia Details
Clinical Trial Site ACTIVE_NOT_RECRUITING Apeldoorn Gelderland 7334 DZ Netherlands Details
Clinical Trial Site ACTIVE_NOT_RECRUITING Seoul Seoul 02841 South Korea Details
Clinical Trial Site ACTIVE_NOT_RECRUITING Seoul Seoul 03080 South Korea Details
Clinical Trial Site ACTIVE_NOT_RECRUITING Chang-hua Chang Hua 50006 Taiwan Details
Clinical Trial Site RECRUITING Kaohsiung City Sanmin 80756 Taiwan Details
Clinical Trial Site ACTIVE_NOT_RECRUITING Bangkok Bangkok 10700 Thailand Details
Clinical Trial Site RECRUITING Dusit Bangkok 10300 Thailand Details
Clinical Trial Site RECRUITING Ban Phaeo Changwat Samut Sakhon 74120 Thailand Details
Clinical Trial Site RECRUITING Hat Yai Changwat Songkhla 90110 Thailand Details
Clinical Trial Site ACTIVE_NOT_RECRUITING Chiang Mai Chiang Mai 50200 Thailand Details
Clinical Trial Site RECRUITING Brighton England BN2 5BE United Kingdom Details
Clinical Trial Site ACTIVE_NOT_RECRUITING London England WC1E 6AG United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field